Medicine and Dentistry
Patient
100%
Gamma Urogastrone
74%
Patritumab
74%
Epidermal Growth Factor Receptor 3
74%
Breast Cancer
69%
Complication
40%
Antibody-Drug Conjugate
37%
Hospital
34%
Cancer Surgery
27%
Mortality
27%
Death
27%
Hormone Receptor
25%
Stomach Cancer
20%
Colorectal Cancer
20%
Diseases
20%
Postoperative Complication
20%
Prospective Cohort Study
13%
Breast
13%
Surgical Mortality
13%
Assessment
12%
Inpatient
12%
Primary Tumor
12%
Single Drug Dose
12%
Boron Neutron Capture Therapy
12%
Messenger RNA
12%
Therapeutic Procedure
12%
Translational Research
12%
Arm
12%
Drug Resistance
12%
Tumor Microenvironment
12%
Evaluation Study
12%
Biological Product
12%
Biological Activity
12%
Surgery
6%
Health
6%
Malignant Neoplasm
6%
Odds Ratio
6%
Global Health
6%
Absence
6%
Adult
6%
Postoperative Care
6%
Cancer Staging
6%
Day of Surgery
6%
Surgical Technique
6%
Skin Incision
6%
Perioperative Period
6%
General Anesthesia
6%
Logistic Regression Analysis
6%
Neuraxial Anesthesia
6%
Pharmacology, Toxicology and Pharmaceutical Science
Gamma Urogastrone
74%
Epidermal Growth Factor Receptor 3
74%
Breast Cancer
62%
Antibody Drug Conjugate
37%
Hormone Receptor
25%
Primary Tumor
12%
Tumor Microenvironment
12%
Biological Product
12%
Messenger RNA
12%
Drug Resistance
12%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
74%
Antibody
37%
Hormone Receptor
25%
Conjugate
25%
Molecular Biology
12%
Drug Resistance
12%
Single Drug Dose
12%
Messenger RNA
12%
Biological Activity
12%
Ultrasound
12%
ERBB3
12%